modern data from Gilead Sciences's ...
modern data from Gilead Sciences's (Foster City, CA) ongoing Phase 3 trial of Viread (tenofovir disoproxil fumarate) point outs the study drug to have favorable tenors on serum lipid profiles and mitochondrial DNA make contented through 48 weeks when taken as part of a combination therapy in antiretroviral-naive HIV enthralls ...
|